About usPharma directory Press kit
package on pharmacy shelves across Ukraine
by sales in physical terms
certification since 2002
investments are directed annually to new products
products with a focus on cardiology, neurology and pain management
products in the development portfolio
pharmaceutical company in the rating of sustainable businesses of Ukraine (Forbes, 2022)
Empowering healthcare professionals and patients to improve quality of life with science, innovation & availability.
At Darnitsa, we attract the best specialists and scientists, the latest pharmaceutical technologies, and progressive discoveries.
Adhering to the highest GMP standards, we are concerned about the availability of our products and their unconditional quality in 15 countries around the world.
90 years of trust among patients and the medical and research community inspire us to new pharmaceutical developments, and we, in turn, inspire everyone to take care of health at the highest level together with Darnitsa.
We are the best at what we do - each of us and all of us together. We think and act outside the box. We are bold and indefatigable. Having reached one lofty target, we set even more daring goals.
Each of us achieves more every day and is responsible as an owner for the ultimate success of the company.
We fullу understand that we are responsible each and every day to our colleagues, patients, the medical community, our partners, society and the planet.
We are proud of the achievements which shape us as leaders and lead us to develop further. These are the approaches, attitudes, standards which have built a solid foundation and that we proudly carry with us: ambition, quality as our DNA, caring for people, resilience in difficult times, foresight.
Executive Chairman, Board of Directors
Pharmaceutical company Darnitsa
CBG Sales & Marketing
Rx Sales & Marketing
OTC Sales & Marketing
Supply & Logistics
Compliance, Сorporate & Legal
Chief Financial Officer
Chief Financial Officer
She possesses over 20 years of successful financial management in international companies in Ukraine and abroad.
In particular, she worked for Procter & Gamble and in a Polish division of the Austrian insurance group UNIQA. Furthermore, Anna has pharmaceutical industry experience - she was a financial manager in the Roche company in Ukraine, a division of the Swiss pharmaceutical company that produces biotechnological drugs for oncology and virology.
She obtained a higher economic education at the Kyiv National University of Economics, later she obtained an EMBA at the Warsaw Business School.